These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3833387)

  • 21. Synthesis of prothymosin alpha deduced from nucleotide sequence of the murine cDNA and its effect on the impaired T lymphocytes of uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):213-20. PubMed ID: 8292970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of two thymosin fraction 5 polypeptides on human peripheral blood lymphocytes.
    Kokkinopoulos D; Perez S; Baxevanis C; Papamichail M
    Immunopharmacol Immunotoxicol; 1987; 9(4):409-19. PubMed ID: 2893819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid phase synthesis of thymosin beta 9.
    Chandramouli N; Bhargava KK; Incefy GS; Modak MJ; Merrifield RB
    Int J Pept Protein Res; 1986 Nov; 28(5):536-41. PubMed ID: 3818171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked reduction in percentage of rosette-forming thymocytes of rats during induction of bladder tumors and restorative effect of thymosin in vitro.
    Kimura S; Ozaki Y; Toyokawa T; Nishio S; Maekawa M; Goldstein AL; Kinoshita Y
    J Natl Cancer Inst; 1986 Apr; 76(4):661-7. PubMed ID: 3485733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of rat parathymosin alpha fragment 1-28 and examination of its inhibitory activity towards the restoring activity of thymosin alpha 1 on the impaired T-lymphocytes of uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2647-52. PubMed ID: 1806285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms.
    Sakal H; Costanzi JJ; Loukas DF; Gagliano RG; Ritzmann SE; Goldstein AL
    Cancer; 1975 Sep; 36(3):974-6. PubMed ID: 1182684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential role of thymosin in the treatment of autoimmune diseases.
    Goldstein AL; Zatz MM; Low TL; Jacobs R
    Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
    [No Abstract]   [Full Text] [Related]  

  • 29. Syntheses of two deacetyl-thymosin beta4 analogs and their anti-inflammatory effect on carrageenin-induced edema in the mouse paw.
    Abiko T; Ogawa R
    Mediators Inflamm; 2001 Apr; 10(2):89-92. PubMed ID: 11405555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-phase synthesis of thymosin beta 4: chemical and biological characterization of the synthetic peptide.
    Low TL; Wang SS; Goldstein AL
    Biochemistry; 1983 Feb; 22(4):733-40. PubMed ID: 6838821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1.
    Schulof RS; Chorba TL; Cleary PA; Palaszynski SR; Alabaster O; Goldstein AL
    Cancer; 1985 Mar; 55(5):974-83. PubMed ID: 3155644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514
    [No Abstract]   [Full Text] [Related]  

  • 33. Separation of rosette formation-inducing polypeptides from the supernatant of cultures of rat thymic epithelial cell line.
    Taniyama T; Kinoshita Y; Hato F; Tominaga K; Kimura S; Itoh T
    Cell Mol Biol; 1989; 35(5):535-45. PubMed ID: 2611839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-phase synthesis of thymosin alpha 1 using tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin.
    Wong TW; Merrifield RB
    Biochemistry; 1980 Jul; 19(14):3233-8. PubMed ID: 7190831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soybean lectin-responding cells in human tonsil--II. An induction of concanavalin A-responsiveness and E-rosette-forming capacity to soybean lectin-responding cells by thymosin.
    Kinoshita Y; Yamaga K; Kimura S; Nakai Y
    Cell Mol Biol; 1986; 32(4):407-10. PubMed ID: 3742550
    [No Abstract]   [Full Text] [Related]  

  • 36. Interleukin-2 production and effect of thymosin fraction 5 on interleukin-2 production in rheumatoid arthritis.
    Wolf RE; Hall VC
    J Rheumatol; 1987 Oct; 14(5):898-901. PubMed ID: 3123674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro restoration by thymosin of T lymphocytes from patients with lung tuberculosis.
    Vladimirsky MA; Streltsov VP; Buchmann VM
    Biomedicine; 1978 Feb; 29(1):3-5. PubMed ID: 307411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response modulation in the spontaneously hypertensive rat.
    Strausser HR
    Thymus; 1983; 5(1):19-33. PubMed ID: 6342214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in purine salvage pathway enzyme activities during human lymphocyte differentiation induced by thymosin fraction 5.
    Cowan MJ; Fraga M; Ammann AJ
    Adv Exp Med Biol; 1984; 165 Pt B():93-8. PubMed ID: 6426270
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of thymosin on human blood lymphocytes in vitro].
    Kosmiadi GA; Grigor'eva MP; Korotaev GK; Il'intseva IE; Grigor'ev MIu
    Vopr Onkol; 1979; 25(10):7-11. PubMed ID: 315663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.